As Vermont manages $38 million in opioid settlement funds, a state-level restriction on law enforcement spending is leaving rural communities vulnerable to rising fentanyl trafficking.
Scientists have identified extrachromosomal DNA (ecDNA) as a key factor in how tumors evolve and resist chemotherapy. These circular DNA fragments carry oncogenes and replicate independently, allowing cancer cells to…
A collaborative study between Roche and Harvard University has led to the discovery of Zosurabalpin, a new antibiotic class that effectively kills carbapenem-resistant Acinetobacter baumannii. The drug works by inhibiting…
Insilico Medicine has advanced the first generative AI-discovered and AI-designed drug candidate into Phase II clinical trials. The drug, INS018_055, targets idiopathic pulmonary fibrosis, a chronic condition that causes progressive…
Vertex Pharmaceuticals has successfully completed Phase 3 trials for suzetrigine, a novel non-opioid pain medication. By targeting specific sodium channels in the peripheral nervous system, the drug blocks pain signals…
Researchers have utilized explainable deep learning to discover a new class of antibiotics capable of killing methicillin-resistant Staphylococcus aureus (MRSA). This breakthrough marks one of the first times AI has…
The Trump administration has successfully narrowed the FDA approval for the drug leucovorin, focusing on a rare genetic brain disorder. This move follows a rigorous review process that prioritized the…
The House committee has released video recordings of former President Bill Clinton and former Secretary of State Hillary Clinton answering questions about Jeffrey Epstein. These depositions, which took place over…
The Trump administration has proposed a new FDA pathway to accelerate the approval of customized treatments for rare genetic diseases. This initiative, known as the plausible mechanism, allows for the…
